Equities

DocMorris Shares Extend Gains After Upgrade and Medi24 Acquisition
DocMorris shares climbed further following an upgrade by Zürcher Kantonalbank and the planned acquisition of Swiss telemedicine provider Medi24.

Swatch and Richemont Shares Rise on Improved Watch Sector Outlook
Swatch and Richemont shares advanced following an improved full-year sales forecast from British retailer Watches of Switzerland.

PSP Swiss Property Posts Higher Nine-Month Profit on Project Sale
PSP Swiss Property reported an increase in operating profit for the first three quarters of 2026, driven largely by the sale of the Richtipark development project in Wallisellen.

Swiss Shares Close at Session Highs as Wall Street Gains on Oil Price Drop
The SMI closed 0.61 percent higher led by Roche and Sika, while US equities advanced following a decline in oil prices and remarks by Donald Trump regarding Iran.

Analyst downgrades weigh on Munich Re and Hannover Rück shares in Frankfurt
JPMorgan downgrades push reinsurers down by about 4 percent each in Frankfurt trade, halting their recent rally amid upcoming pricing pressures.

SMI Under Pressure After Record High With Swiss Life and Zurich in Focus
US inflation data and corporate earnings from firms including Swiss Life, Zurich, and Richemont take center stage as the Swiss market retreats.

Deutsche Bank Tech Upgrade Precedes Market Slump, Lonza Acquires Merck Sites
Deutsche Bank upgrades the technology sector hours before a market pullback, while Lonza announces a multi-million franc acquisition of Merck production sites.

Rheinmetall Shares Plunge Over 17% Following Profit Warning
German defence group Rheinmetall cuts annual sales and profit margin forecasts due to delayed orders, pushing the wider European defence sector down.

Arbonia Shares Fall Following Target Cuts and Guidance Revision
Swiss building supplier Arbonia saw its shares decline after analysts lowered their price targets following a revenue and profit warning for 2026.

Frankfurt Stocks End Rally at Record High Amid US Market Turbulence
German equities retreated from record highs as US market turbulence and corporate earnings weighed on sentiment.

UBS shares dip 0.27% after Wednesday surge, market focus on capital rules and merger talk
UBS stock fell 0.27% to CHF 41.17 as the SMI rose, following a 4.59% jump on Wednesday driven by bank‑stock demand, US midterm results, capital‑rule proposals and Morgan Stanley merger speculation.

European equities rally after US midterms, DAX hits record high
European stocks rose on Thursday, with Germany’s DAX up 0.8% to a record 26,654.56 points and the Swiss SMI holding above 15,000, as optimism follows the US mid‑term results.

Swiss Market Index Crosses 15,000 Points for the First Time
The Swiss benchmark index climbed past 15,000 points on Wednesday, driven by gains in major heavyweights and the results of the US midterm elections.

Swiss Pharma and Chemical Sector Retains Global Standing but Trails in Innovation
A new BAK Economics study places Switzerland third globally in chemicals and pharmaceuticals, while noting vulnerabilities in clinical trials, AI adoption, and innovation.

Swisscom Expected to Post Higher Nine-Month Profit Despite Lower Revenue
Analysts forecast Swisscom will report lower nine-month revenue but higher earnings, driven by price hikes and integration synergies.

Swiss Shares Driven by Corporate News Rather Than US Midterms
Investors on the Swiss stock market show a subdued reaction to the US midterm elections as individual corporate developments drive market movements.

Swiss Market Index Closes Lower as Heavyweights Fall; Burckhardt Compression Jumps on Orders
The Swiss stock market ended Tuesday in negative territory, led lower by pharmaceutical giant Roche and plumbing supplier Geberit, while Burckhardt Compression surged.

Swiss Market Index Closes Lower as Pharma Weights Offset Gains
The Swiss market ended the session slightly down, weighed down by pharmaceutical heavyweights while broader equities showed resilience.

Swiss Market Index Closes at Record High as Defensive Shares Gain Ground
The Swiss stock exchange advanced despite weak overseas markets, driven by demand for defensive equities, while technology shares declined broadly.

US Midterms, Tech Earnings and Employment Report Set to Test Global Markets
Equities face a packed calendar featuring upcoming corporate results from Apple, AMD and Palantir, key US economic data, and the congressional midterms.

Barclays Raises Lonza Price Target as Shares Climb Toward Five-Year High
British investment bank Barclays has raised its price target for Swiss pharmaceutical supplier Lonza to 770 francs from 730 francs, maintaining an Overweight rating.

SMI Seen Opening Higher as Wall Street Gains and Oil Prices Slip
Pre-market indicators point to a positive start for the Swiss stock exchange, following higher closes on Wall Street and ongoing technology earnings.

German Shares Advance Ahead of US Tech Earnings and Central Bank Decisions
The Dax rose ahead of upcoming quarterly reports from major US technology companies and interest rate decisions from the Federal Reserve, European Central Bank and Bank of Japan.

UBS CEO Ermotti Raises Pressure Over Capital Rules, Warns on Relocation
UBS Chief Executive Officer Sergio Ermotti raised the prospect of relocating the bank's headquarters abroad amid stringent Swiss capital proposals.